U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 8 of 8 results

Status:
US Approved Rx (2018)
First approved in 1946

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Dihydroergotamine (DHE) is a semisynthetic, hydrogenated ergot alkaloid, synthesized by reducing an unsaturated bond in ergotamine. Dihydroergotamine was originally envisaged as an antihypertensive agent, but it was later shown to be highly effective...
Alpha-ergocryptine is a component of the ergotoxine complex; it is the main ergot alkaloid of Japanese & South American wid grasses. Alpha-ergocryptine is an agonist at the D2 dopamine receptor. Alpha-ergocryptine effectively decreases intraocula...
Status:
Other

Class (Stereo):
CHEMICAL (ABSOLUTE)


Ergocryptinine is the ergot alkaloid. Ergotaminine, ergocryptinine, ergosinine and ergocorninine show vasoconstrictory effect, i.e. they cause the contraction of smooth muscles of blood vessels. Ergocryptinine shortened the duration of arrhythmia ind...
Ergocornine is an ergot alkaloid. Ergocornine can inhibit prolactin release by a direct action on the anterior pituitary. It can modulate activity at both dopamine and serotonin receptors.
Status:
US Previously Marketed
First approved in 1951

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dihydroergocornine is an ergot alkaloid, one of the three components of ergoloid (trade name Hydergine). Dihydroergocornine (as the component of Ergoloid mesylates) has been used to treat dementia and age-related cognitive impairment (such as in Alz...
Status:
US Approved Rx (2018)
First approved in 1946

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Dihydroergotamine (DHE) is a semisynthetic, hydrogenated ergot alkaloid, synthesized by reducing an unsaturated bond in ergotamine. Dihydroergotamine was originally envisaged as an antihypertensive agent, but it was later shown to be highly effective...
Status:
US Approved Rx (2018)
First approved in 1946

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Dihydroergotamine (DHE) is a semisynthetic, hydrogenated ergot alkaloid, synthesized by reducing an unsaturated bond in ergotamine. Dihydroergotamine was originally envisaged as an antihypertensive agent, but it was later shown to be highly effective...
Status:
US Previously Marketed
First approved in 1951

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dihydroergocornine is an ergot alkaloid, one of the three components of ergoloid (trade name Hydergine). Dihydroergocornine (as the component of Ergoloid mesylates) has been used to treat dementia and age-related cognitive impairment (such as in Alz...